PURPOSE: Negative physical functioning outcomes including incontinence and erectile dysfunction are relatively common following radical prostatectomy (RP) and are associated with treatment regret and compromised quality of life (QOL). The role that treatment regret may have in influencing the association between prostate-specific QOL (i.e., sexual, urinary, bowl functioning) and general QOL following RP has not been examined. METHOD: This study examined the associations of treatment regret, general QOL (36-item Short Form Health Survey physical and mental health (MCS) composite scores), and prostate-specific QOL (Prostate Cancer QOL sexual, urinary, bowl functioning, and cancer worry subscales) in 95 men who underwent RP for prostate cancer. RESULTS: Multiple regression analyses indicated that poorer sexual and urinary functioning was associated with poorer MCS. Additionally, men with lower sexual and urinary functioning reported greater treatment regret. Treatment regret was also associated with lower MCS. Finally, treatment regret partially mediated the effects of both sexual and urinary functioning on MCS. CONCLUSIONS: These findings suggest that regardless of a patient's prostate-specific QOL, reducing treatment regret may improve mental health following RP. Though there are limited options to alter patients' sexual or urinary functioning following RP, treatment regret may be a modifiable contributor to post-surgical adjustment and QOL.
PURPOSE: Negative physical functioning outcomes including incontinence and erectile dysfunction are relatively common following radical prostatectomy (RP) and are associated with treatment regret and compromised quality of life (QOL). The role that treatment regret may have in influencing the association between prostate-specific QOL (i.e., sexual, urinary, bowl functioning) and general QOL following RP has not been examined. METHOD: This study examined the associations of treatment regret, general QOL (36-item Short Form Health Survey physical and mental health (MCS) composite scores), and prostate-specific QOL (Prostate Cancer QOL sexual, urinary, bowl functioning, and cancer worry subscales) in 95 men who underwent RP for prostate cancer. RESULTS: Multiple regression analyses indicated that poorer sexual and urinary functioning was associated with poorer MCS. Additionally, men with lower sexual and urinary functioning reported greater treatment regret. Treatment regret was also associated with lower MCS. Finally, treatment regret partially mediated the effects of both sexual and urinary functioning on MCS. CONCLUSIONS: These findings suggest that regardless of a patient's prostate-specific QOL, reducing treatment regret may improve mental health following RP. Though there are limited options to alter patients' sexual or urinary functioning following RP, treatment regret may be a modifiable contributor to post-surgical adjustment and QOL.
Authors: David F Penson; Ziding Feng; Alan Kuniyuki; Dale McClerran; Peter C Albertsen; Dennis Deapen; Frank Gilliland; Richard Hoffman; Robert A Stephenson; Arnold L Potosky; Janet L Stanford Journal: J Clin Oncol Date: 2003-03-15 Impact factor: 44.544
Authors: Lisa Yan; Diane M Da Silva; Bhavna Verma; Andrew Gray; Heike E Brand; Joseph G Skeate; Tania B Porras; Shreya Kanodia; W Martin Kast Journal: Prostate Date: 2014-11-14 Impact factor: 4.104
Authors: B A Mahal; M-H Chen; C L Bennett; M W Kattan; O Sartor; K Stein; A V D'Amico; P L Nguyen Journal: Prostate Cancer Prostatic Dis Date: 2014-10-28 Impact factor: 5.554
Authors: Daniela Wittmann; Marsha Carolan; Barbara Given; Ted A Skolarus; Heather Crossley; Lawrence An; Ganesh Palapattu; Patricia Clark; James E Montie Journal: J Sex Med Date: 2014-10-31 Impact factor: 3.802
Authors: Nnenaya Agochukwu-Mmonu; Adharsh Murali; Daniela Wittmann; Brian Denton; Rodney L Dunn; James Montie; James Peabody; David Miller; Karandeep Singh Journal: Eur Urol Open Sci Date: 2022-04-18